Navigation Links
Professor Zvi Ram presents phase III recurrent glioblastoma survival and quality of life data from the first pivotal study of the NovoTTF-100A at 15th Annual Society for Neuro-Oncology Scientific Meeting
Date:11/19/2010

the age of 60 who were able to maintain normal daily activities (KPS>80 percent) at the time of enrollment achieved a significant increase in median overall survival time (8.8 vs. 6.6 months, n=110, p< 0.01) and in the 1-year survival rate (35 percent vs. 20 percent, n=110, p< 0.01) when treated with TTF Therapy versus effective chemotherapies. TTF therapy also produced a significant increase in survival time for patients who had failed treatment with bevacizumab (Avastin; Roche) prior to enrollment (4.4 vs. 3.1 months, n=44, p< 0.02). Patients enrolled in the study also reported superior quality of life scores (EORTC QLQ-C30) across a range of lifestyle and symptom categories for TTF therapy compared to the chemotherapy-treated control group.

"The data presented at SNO further validate TTF therapy as a potential treatment option for patients with recurrent glioblastoma tumors," said Asaf Danziger, chief executive officer of Novocure, the trial sponsor. "The suggested improvement in quality of life scores reported by patients receiving TTF therapy is particularly important given the nature of this disease and the strong desire among patients and their caregivers to avoid the side-effects of chemotherapy and radiation."

TTF therapy has been shown in vitro to slow and reverse tumor cell proliferation by inhibiting mitosis, the process by which cells divide and replicate. The NovoTTF-100A device, which weighs about six pounds (three kilograms), creates a low-intensity, alternating electric field within the tumor that exerts physical forces on electrically charged cellular components, preventing the normal mitotic process and causing cancer cell death prior to division.

Novocure is now sponsoring a second phase III study of TTF therapy at 26 centers in the US, Europe, and Israel. This study will enroll 283 patients with newly diagnosed glioblastoma tumors. Patients will be randomized (2 to 1) to receive TTF therapy and temozolomide (Temo
'/>"/>

Contact: Frank Leonard
frank@novo-cure.com
917-656-3518
Edelman Public Relations
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Professor John Shine wins 2010 Prime Ministers Prize for Science
2. CancerCare names Jefferson professor Physician of the Year
3. Professor Cesare Montecucco to receive the 2011 Paul Ehrlich and Ludwig Darmstaedter Prize
4. UT professor defines play, discovers even turtles need recess
5. Virginia Tech professor discovers new TB pathogen
6. Drug to treat alcoholism goal of UH professors research
7. K-State professors book is first to explore Two-Spirit literature in Northwest native groups
8. Louisiana Tech kinesiology professor receives national editorial excellence award
9. WPI computer science professor receives HP Labs Innovation Research Award
10. Linguistics professor examines manufacturers prescription drug websites
11. NJIT professor heads panel studying sudden car acceleration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... Healthegy, ... announced the two leaders who will deliver keynote presentations at the upcoming Digital ... Mandarin Oriental Hotel in Boston. , Larry Renfro, CEO of Optum, will deliver ...
(Date:9/2/2015)... ... September 02, 2015 , ... Based in Beverly Hills, Luxury ... truly superb luxury vehicles based on which of the latest and greatest vehicles their ... step forward in pursuit of this goal: a 2015 Rolls Royce Wraith rental ...
(Date:9/2/2015)... ... September 02, 2015 , ... The Western ... and Mildred Goldstein Charitable Trust to establish the Abraham and Mildred Goldstein Endowment ... months after WCHN recruited nationally known gynecologic oncologist Thomas J. Rutherford, MD, PhD ...
(Date:9/2/2015)... ... 2015 , ... Date and time: Oct. 3, 2015, 9 a.m. to 4 ... Road, Bryn Athyn, Pa 19009 , Cost: $50 per person; includes lunch , The ... best-selling author Sam Keen based on his new book which he co-authored with his ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... safety and efficacy endpoint data collection, cloud analytics and workflow solutions today ... The series enables pharmaceutical researchers to participate in interactive programs in which ...
Breaking Medicine News(10 mins):Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 3Health News:Luxury Line Auto Rental Announces Addition of the Rolls Royce Wraith to their Luxury Fleet 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 3Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 3
... Dec. 2 TROY Group, Inc.,(Pink Sheets: TROY), ... the first digital printer for printing the federally,mandated ... TROY SecureRx,printer allows healthcare providers to significantly reduce ... security regulations,established by the Center for Medicare and ...
... SAN JOSE, Calif., Dec. 2 eOn Communications,Corporation(TM) (Nasdaq: ... announced today that it has received a contract from ... at the Landstuhl Regional Medical,Center in Germany. Implementation ... April of 2009. , ...
... Shower(TM) brand just got,better with the addition of its new ... flavor contains Lifeguard(TM) Protection, a fortification,package with powerful antioxidant vitamins ... leading brands. , "We ... Sun Shower(TM) Super,Blends iced coffees, teas and lattes," said Chris ...
... SACRAMENTO, Calif., Dec. 2 MRME the publisher of ... the American,College of Cardiology (CA ACC), the largest ACC ... and impactful educational programs for,cardiologists. The CA ACC is ... of medical education activities. , ...
... and improves attention to the scan, study shows , , TUESDAY, ... the patient next to their radiological scans helps humanize each ... by radiologists, a new study finds. , As technological ... patient, putting a patient,s photo in his or her file ...
... MANCHESTER, N.H., Dec. 2 Anthem Blue Cross and ... have pledged more than,$175,000 to support over 220 not-for-profit ... Giving Campaign. The Anthem Blue Cross and Blue,Shield Foundation ... the total to more than $260,000 , ...
Cached Medicine News:Health News:TROY SecureRx Revolutionizes Prescription Printing 2Health News:TROY SecureRx Revolutionizes Prescription Printing 3Health News:TROY SecureRx Revolutionizes Prescription Printing 4Health News:eOn Communications Announces GSA Contract 2Health News:eOn Communications Announces GSA Contract 3Health News:New Sun Shower(TM) Super Blends: Iced Coffees, Teas, Lattes With Half the Calories 2Health News:Patients' Photos Help Boost Radiologists' Accuracy 2Health News:Anthem Blue Cross and Blue Shield in New Hampshire Associates Pledge More Than $260,000 to Community Organizations 2Health News:Anthem Blue Cross and Blue Shield in New Hampshire Associates Pledge More Than $260,000 to Community Organizations 3
(Date:9/2/2015)... Sept. 2, 2015 About Chronic Lymphocytic Leukemia ... condition characterized by increased production of lymphocytes. It has ... then it can spread to other parts of the ... because of the slow buildup of the cancerous cells. ... to the spleen, liver, and lymph nodes. The course ...
(Date:9/2/2015)... and Markets ( http://www.researchandmarkets.com/research/l8z67c/pharmaceutical ) has announced the addition of ... November 26-27, 2015)" conference to their offering. ... key areas of pharmaceutical regulatory affairs in China ... Macau and Taiwan and ... gaining and maintaining a successful Marketing Authorisation in the region ...
(Date:9/2/2015)... Gulf Coast Tattoo Removal is the first and only laser ... in Southern Mississippi . Gulf Coast Tattoo Removal ... back control of their skin. The clinic is located in ... Biloxi , Gulfport , and the ... prevalent as it is, I was surprised by the lack of ...
Breaking Medicine Technology:Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 3Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2Gulf Coast Tattoo Removal Delivers Unrivaled Tattoo Removal Results To Biloxi And Gulfport With Astanza Duality 2
... 2007 /PRNewswire/ -- GlaxoSmithKline today,announced results from ... or metastatic renal cell carcinoma (RCC), ovarian ... were presented at the,43rd Annual Meeting of ... Chicago. The results observed in these trials ...
... 4, 2007 - Hemispherx Biopharma, Inc.,(AMEX: HEB), ... of new drug entities for the treatment ... scientific report on the,activity of its experimental ... against highly pathogenic avian,influenza (HPAI), also known ...
Cached Medicine Technology:GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 2GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 3GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 4GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 5GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 6GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 7Hemispherx Presents Evidence of Ampligen Synergies with Existing,Antivirals at International Avian Influenza Conference 2Hemispherx Presents Evidence of Ampligen Synergies with Existing,Antivirals at International Avian Influenza Conference 3
Trial lens set +/- Cyl....
...
... of engineering and innovative design, the Burton ... and masterful workmanship. At Burton, we set ... industry a truly innovative concept, but to ... to quality construction and stringent testing, we ...
... Durable cast iron and steel construction for ... quiet and reliable up/down chair movement. Soft, ... of lasting comfort. Electro-magnetic counter-balanced slit lamp ... Low, only 24" high slit lamp arm ...
Medicine Products: